MRI Techniques to Treat Seizure Disorders

Overview

About this study

This study is designed to use new MRI techniques to better understand and treat seizure disorders

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Subjects with medically refractory epileptogenic foci that are determined to be surgical candidates will be included (e.g. mesial temporal sclerosis patients suffering from medical refractory epilepsy who are being evaluated prior to temporal lobectomy)

Exclusion Criteria:

  • Non-focal epilepsy disorder
  • Confounding CNS pathology that may theoretically interfere with data processing or intrinsic resting state networks (e.g. large stroke, high grade glioma, neurodegenerative illness).
  • Pregnancy

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Kirk Welker, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions